Parkinsonism is a common complication of neuroleptic drug use; however, the pathophysiology of the persistence of parkinsonian symptoms after withdrawal of neuroleptic drugs is poorly understood. Twenty patients with neuroleptic induced parkinsonism were studied by high field MRI. Persistence of symptoms was associated with different findings depending on the age of the patients-namely, putaminal hypointensity in young patients and striatal hyperintensities in old patients. High field MRI may be useful in identifying patients at higher risk for neuroleptic induced parkinsonism.
The clinical course of neuroleptic induced parkinsonism after withdrawal of neuroleptic drugs may be characterised by rapid remission of symptoms (within five to 60 days), by persistence of symptoms, or by further progressive deterioration.'-6 Whereas it is generally agreed that the extrapyramidal symptoms are linked to the functional blockade of postsynaptic dopaminergic receptors, several mechanisms have been suggested to explain the pathophysiology of progressive or persistent forms. Studies using PET have shown a high degree of correlation between persistence or progression of symptoms and low putaminal uptake of '8F-dopa.7 Genetic factors,8 toxicity of neuroleptic drugs beyond dopaminergic Table 1 Demographic and clinical characteristics ofpatients with neuroleptic induced parkinsonism (NIP)
Young NIP (n = 10)
Old NIP (n = 10) (mean (SD)) (mean (SD))
Age (y) 34-6 (6 9) 65-6 (3 9) Education (y) 13-7 (3 4) 5-0 (4 0) MMSE 25-6 (5 8) 22 Symptom duration (y) 9-8 (6-6)
(4 2)
Neuroleptic treatment (y) 
Results
Clinical presentation differed between young and old patients with neuroleptic induced parkinsonism. Among the 10 young patients, eight had bradykinesia as the predominant symptom associated with postural tremor or rigidity, and two complained mainly of tremor. None of these patients had vascular risk factors. Among the old patients, eight complained chiefly of tremor (rest tremor in five and postural tremor in three) with associated rigidity in five and bradykinesia in three. Two patients had only a rigid-akinetic syndrome without tremor. In seven patients symptoms were bilateral and symmetric. Three of these patients had high blood pressure and two had In conclusion, even though the results of this study must be considered as preliminary and need to be confirmed on a larger number of patients, techniques such as MRI may be useful in identifying patients at higher risk for developing neuroleptic induced parkinsonism.
